ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2023 | $1,342 | -24.0% | 200 | 0.0% | 0.00% | – |
Q1 2023 | $1,766 | +15.6% | 200 | 0.0% | 0.00% | – |
Q4 2022 | $1,528 | – | 200 | – | 0.00% | – |
Q3 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2022 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | -84.2% | 200 | -71.1% | 0.00% | -100.0% |
Q4 2021 | $19,000 | +171.4% | 692 | +232.7% | 0.00% | – |
Q3 2021 | $7,000 | -12.5% | 208 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $8,000 | -75.8% | 208 | -74.3% | 0.00% | -50.0% |
Q1 2021 | $33,000 | +175.0% | 808 | +288.5% | 0.00% | +100.0% |
Q4 2020 | $12,000 | +20.0% | 208 | +4.0% | 0.00% | 0.0% |
Q3 2020 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $10,000 | +66.7% | 200 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $6,000 | – | 200 | – | 0.00% | – |
Q2 2019 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |